Skip to Main Content
Table I.

Effects of anti-CD14 mAba

Additors During PrimingDNA Synthesis (cpm/Culture)
LPS 8932 ± 247 
Anti-CD14 mAb MEM-18 + LPS 564 ± 139 
TT 3921 ± 210 
Anti-CD14 mAb MEM-18 + TT 3942 ± 354 
SEB 7954 ± 467 
Anti-CD14 mAb MEM-18 + SEB 8621 ± 1087 
Medium control 231 ± 43 
Anti-CD14 mAb MEM-18 + medium control 198 ± 23 
Additors During PrimingDNA Synthesis (cpm/Culture)
LPS 8932 ± 247 
Anti-CD14 mAb MEM-18 + LPS 564 ± 139 
TT 3921 ± 210 
Anti-CD14 mAb MEM-18 + TT 3942 ± 354 
SEB 7954 ± 467 
Anti-CD14 mAb MEM-18 + SEB 8621 ± 1087 
Medium control 231 ± 43 
Anti-CD14 mAb MEM-18 + medium control 198 ± 23 
a

Purified monocytes were preincubated with or without anti-CD14 mAb MEM-18 and then primed LPS, TT, or SEB for 1 h. For further details, see Materials and Methods. These primed monocytes (1 × 105/ml) were added to purified autologous T lymphocytes (1 × 106/ml). DNA synthesis was measured after 4 days in SEB-stimulated cultures or after 7 days in LPS, TT, or unstimulated cultures, respectively. Data are expressed as mean ± SD of three parallel cultures.

Close Modal

or Create an Account

Close Modal
Close Modal